Matthew K Fust Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew K Fust.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew K Fust. Matthew K Fust is Chief Financial Officer in ONYX PHARMACEUTICALS INC ($ONXX).
Latest Insider Trading Transactions of Matthew K Fust
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Option Exercise | M | 34.48 | 17,492 | 603,124 | 72,008 | |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 71.93 | 373 | 26,830 | 63,407 | 63.8 K to 63.4 K (-0.58 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 71.63 | 6,636 | 475,337 | 63,780 | 70.4 K to 63.8 K (-9.42 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 71.74 | 15,000 | 1,076,100 | 70,416 | 85.4 K to 70.4 K (-17.56 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Buy | M | 34.48 | 17,492 | 603,124 | 85,416 | 67.9 K to 85.4 K (+25.75 %) |
Jul 27 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 73.97 | 5,207 | 385,171 | 67,924 | 73.1 K to 67.9 K (-7.12 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Option Exercise | A | 37.68 | 45,900 | 1,729,512 | 45,900 | |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | D | 36.58 | 820 | 29,993 | 72,810 | 73.6 K to 72.8 K (-1.11 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | D | 36.58 | 757 | 27,688 | 73,630 | 74.4 K to 73.6 K (-1.02 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Grant | A | 0.00 | 17,150 | 0 | 74,387 | 57.2 K to 74.4 K (+29.96 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 57,237 | 48.2 K to 57.2 K (+18.66 %) |
Mar 06 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 37.52 | 592 | 22,212 | 48,237 | 48.8 K to 48.2 K (-1.21 %) |
Feb 16 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Option Exercise | D | 34.48 | 5,000 | 172,400 | 89,500 | |
Feb 16 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Buy | M | 34.48 | 5,000 | 172,400 | 48,829 | 43.8 K to 48.8 K (+11.41 %) |
Jan 10 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 43.46 | 1,789 | 77,750 | 43,829 | 45.6 K to 43.8 K (-3.92 %) |
Nov 21 2011 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 38.05 | 867 | 32,989 | 45,310 | 46.2 K to 45.3 K (-1.88 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Option Exercise | A | 35.18 | 42,000 | 1,477,560 | 42,000 | |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Sell | S | 35.02 | 800 | 28,016 | 45,801 | 46.6 K to 45.8 K (-1.72 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Grant | A | 0.00 | 22,500 | 0 | 46,601 | 24.1 K to 46.6 K (+93.36 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 24,101 | 18.1 K to 24.1 K (+33.15 %) |
Page: 1